AbbVie has an attractive 2.7% yield, a solid pharmaceutical business, and is clearly focused on its dividend.
AbbVie has an attractive 2.7% yield, a solid pharmaceutical business, and is clearly focused on its dividend.
Why Wall Street can't get enough of this dividend king
Login to unlock109characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.